Matching geography Reports matching your search in: Join Alert Me now! Receive bi-weekly email alerts on new market research Sign up today!
|
Biotechnology: market research reports
The biotechnology industry encompasses the spectrum of life science-based research companies developing products and services for a wide variety of industries and applications. The industry holds the promise of transformative technologies from agriculture to materials science to environmental science to medicine. In agriculture, biotech products enhance crop yield, advance the nutritional value and quality of crops and livestock, and improve the efficacy and safety of pesticides. In material science, biotechnology is adding to advances in polymer science and the coatings industry. In environmental science, biotech has contributed innovative solutions to environmental clean-up and waste management.
The biggest direct impact of biotechnology, and the biggest market for its products, is in medicine and healthcare. The biotechnology industry is, in many ways, becoming the research and development engine of the pharmaceutical industry. The tools and techniques of genetic analysis and manipulation are at the heart of the drug discovery process, and many of the largest biotech firms have been transformed over the past decade into pharmaceutical and biopharmaceutical giants.
The biotechnology category covers the companies, technologies, tools, and applications of the advanced life science sector. Included are reports on research methods and equipment such as liquid chromatography, mass spectroscopy, genetic sequencing, gene expression, etc. There are also reports on the business of biotechnology, mergers & acquisitions, and funding. Insofar as the sector intersects with the pharmaceutical industry, there are also reports on product pipelines, strategies for drug development and manufacturing such as biogenerics, biosimilars and biomanufacturing. Reports cover so-called green- and white-biotech sectors as well.
Biotechnology market research reports and industry analysis
Lithuania – Bioeconomic Outlook
5/16/2013 | published by: Oryx Business Intelligence Ltd.
... for growth in the future. The report assembles and presents the pertinent statistics along with the interpretation of statistics presented. Interspersed with 14 data tables, figures and charts, the report provides an easy to understand ...
|
read more...
|
$127.00
|
|
|
$3,500.00
|
Banyan Biomarkers - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... company offers biomarkers for traumatic brain injuries and strokes, psychiatric disorders, neuroinflammation, apoptosis, necrosis, and liver injuries. It provides biomarkers for stroke, Alzheimer’s disease, Parkinson’s and Huntington’s disease, and depression; and therapeutic candidates for neuro-protection. ...
|
read more...
|
$750.00
|
Caprion Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... discovery and clinical validation of biomarkers using its proteomics discovery platform CellCarta. Caprion’s CellCarta is used in profiling proteins in solid tissues and plasma. It develops in-vitro diagnostic product candidates in the areas of infectious ...
|
read more...
|
$750.00
|
|
|
$750.00
|
|
|
$750.00
|
Biocortech - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... of depression; and EDITOX, drug screening assay predictive of neuropsychiatric toxicology of chemical entities. The company provides clinical diagnostic tests and drug screening assays. Biocortech has developed a vitro cell line assay to assess candidate ...
|
read more...
|
$750.00
|
Biocrates Life Sciences AG - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... nervous system disorders, gynecology, sports, nutrition, diabetics, pharmaceutical research and endocrinology. Its product portfolio includes Research Products comprising AbsoluteIDQ Kits and Diagnostic Products including MetaDisIDQKit and SteroIDQ Kit. The company offers partners with pharmaceutical, biotechnology ...
|
read more...
|
$750.00
|
|
|
$750.00
|
Digna Biotech, S.L. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... key franchises, four diagnostic tests, and two research products. Digna’s therapeutic areas include P144, P17, IFN alfa 5, cardiotrophin -1 (CT-1), AAV-phorphyria, IFN +CT1 + oncostatin and MTA. The company focuses research and development in ...
|
read more...
|
$750.00
|
AbSorber AB - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... xenotransplantation, and develops techniques for removing antibodies against alpha-Gal and for reducing the immunogenicity of neural stem cells. Its products are used in the treatment of neurological disorders. The company conducts researches on developing ABO ...
|
read more...
|
$750.00
|
Adocia (ADOC) - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... its BioChaperone state-of-the-art technological platform. Its pipeline products include BioChaperone PDGF for chronic wound healing, BioChaperone insulins for insulinotherapy and BioChaperone for monoclonal antibodies. The company has completed two phases I and II studies on ...
|
read more...
|
$750.00
|
|
|
$750.00
|
XDx, Inc. - Product Pipeline Analysis, 2013 Update
5/9/2013 | published by: GlobalData
... rejection and autoimmune diseases. Gene expression patterns reflect the activity of genes in the various blood cells types. XDx provides modern genomics and bioinformatics technology to develop molecular diagnostic assays. The company pipeline product focused ...
|
read more...
|
$750.00
|
|
|
$4,500.00
|
|
|
$125.00
|
|
|
$125.00
|
|
|
$125.00
|
|
|
$125.00
|
|
|
$125.00
|
Ardea Biosciences, Inc. - Strategic SWOT Analysis Review
5/7/2013 | published by: GlobalData
... includes three pipeline products, namely, Lesinurad (RDEA 594), RDEA 3170 and Bay 86-9766 (RDEA 119). Lesinurad and RDEA 3170 are currently in Phase-III and Phase-I clinical trials respectively, being developed as a treatment for gout. ...
|
read more...
|
$125.00
|
|
|
$125.00
|
|
|
$125.00
|
Novavax, Inc. (NVAX) - Financial and Strategic SWOT Analysis Review
5/3/2013 | published by: GlobalData
... and recombinant protein micelle vaccines technology. The company's product portfolio includes vaccines indicated against seasonal quadrivalent influenza, pandemic (H5N1) influenza, respiratory syncytial virus, seasonal trivalent influenza, pandemic (H1N1) influenza and rabies. Novavax established various partnerships ...
|
read more...
|
$125.00
|
Global Biochips Market 2012-2016
5/3/2013 | published by: Infiniti Research Limited
... the growing need for high speed diagnosis. The Global Biochips market has also been witnessing the high cost of deployment. However, the increasing outsourcing activities could pose a challenge to the growth of this market. ...
|
read more...
|
$2,000.00
|
< prev 1 2 3 4 5 6 7 8 9 10 next >
|